Myrobalan Receives Grant to Develop MRO-002 for Multiple Sclerosis
13 Mar 2025 //
BUSINESSWIRE
Myrobalan Appoints Robin Kleiman Ph.D. as Chief Scientific Officer
31 Oct 2024 //
BUSINESSWIRE
Myrobalan Appoints Emma Reeve To Its Board Of Directors
16 Oct 2024 //
BUSINESSWIRE
Myrobalan to present GPR17 antagonist preclinical data at ECTRIMS 2024
18 Sep 2024 //
BUSINESSWIRE
Myrobalan Therapeutics Names Grant Bogle to Board of Directors
29 Jul 2024 //
BUSINESSWIRE
Myrobalan Receives a Grant to Advance its CSF1R Inhibitor Program
07 Feb 2024 //
BUSINESSWIRE